The Diagnostic Ability of White Light Endoscopy & Magnifying Endoscopy

Status Recruiting

Clinical Trial Summary

The purpose of this study is to valuation of the diagnostic ability of white light imaging and magnifying endoscopy with optical enhancement system in early gastric cancer and intraepithelial neoplasia.

Clinical Trial Description

Stomach cancer is the second most common cause of cancer death. Endoscopic identification and treatment of gastric intestinal metaplasia (GIM) and early gastric cancer (EGC) is essential to improve patients' 5-year survival rates. Conventional endoscopy with white light imaging (WLI) is widely used for endoscopic evaluation of EGCs. However, conventional endoscopic visualization of EGCs has a high rate of interobserver variability and correlates poorly with the histological findings. For this reason, diagnosis has been based mostly on repeated endoscopy with multiple biopsy samples. It has been reported that optical enhancement (OE) system is useful for discriminating cancerous lesions from non-cancerous lesions. The OE system is the newly developed image-enhanced endoscopic technology, which combines high definition white light endoscopy (WLE) and optical filters that limit the spectral characteristics of the illumination light. The optical filters can achieve higher overall transmittance by connecting the peaks of the hemoglobin absorption spectrum creating a continuous wavelength spectrum. Magnifying endoscopy is useful for observing the mucosal structures and microvessels. The VS theory proposed by Yao K is widely used in Magnifying endoscopy with optical enhancement system (ME-OE). Based on technical considerations, it is conceivable that ME-OE imaging techniques might have a distinct advantage over WLE in the diagnosis of endoscopic lesions. However, few reports have objectively proved that ME-OE is superior to WLE in the detection rate and diagnostic efficiency of EGCs. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04411589
Study type	Interventional
Source	Shandong University
Contact	Yanqing Li, MD, PhD
Phone	86-531-82169236
Email	liyanqing@sdu.edu.cn
Status	Recruiting
Phase	N/A
Start date	May 1, 2020
Completion date	May 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04977401` - EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjection	N/A
Not yet recruiting	`NCT04083573` - Comparison of Diagnostic Performance of Medical Monitor and Medical Augmented Reality Glasses in Endoscopy: Observation Study
Completed	`NCT02504164` - Effect of Midazolam Premedication on the Satisfaction Levels of Patients After Endoscopic Submucosal Dissection	N/A
Recruiting	`NCT01774266` - Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer	N/A
Completed	`NCT01921283` - Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring	N/A
Completed	`NCT01435525` - Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation	N/A
Completed	`NCT01364324` - Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
Recruiting	`NCT03837301` - Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2)	Phase 2
Recruiting	`NCT05269056` - Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
Not yet recruiting	`NCT03632746` - Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients
Completed	`NCT01938326` - Pure Single Incision Laparoscopic Distal Gastrectomy (SIDG) Versus Totally Laparoscopic Distal Gastrectomy (TLDG)	N/A
Recruiting	`NCT04602689` - Fibrin Glue After ESD for High Risk Patients of Bleeding	N/A
Recruiting	`NCT05291728` - Screening for Early Gastric Cancer in Shaanxi Province
Not yet recruiting	`NCT06152783` - Confocal Laser Microendoscopy (CellTouch) for the Diagnosis of Early Gastric Cancer: A Multicenter Clinical Study
Completed	`NCT02189226` - Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection	N/A
Completed	`NCT04602299` - Setting the Shortest Examination Time of Gastroscopy to Improve the Detection Rate of Upper Gastrointestinal Tumors	N/A
Completed	`NCT02562976` - OLGA Stage is More Appropriate in Predicting Early Gastric Cancer	N/A
Recruiting	`NCT01132469` - Efficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer	N/A
Completed	`NCT03136354` - Prospective Randomized Trial Comparing Endoscopic Submucosal Dissection Against Laparoscopic Assisted Gastrectomy for Treatment of Early Gastric Cancer	N/A
Completed	`NCT02216110` - Endoscopic Submucosal Dissection Versus Gastrectomy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Diagnostic Ability of White Light Endoscopy and Magnifying Endoscopy With Optical Enhancement System

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms